Read + Share
Kapp-Schwoerer S, Weber D, Corbacioglu A, Gaidzik VI, et al. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with
NPM1-mutated AML: results from the AMLSG 09-09 trial. Blood 2020;136:3041-3050.
PMID: 33367545
|
 |
|
Kapp-Schwoerer S, Weber D, Corbacioglu A, Gaidzik VI, et al. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with
NPM1-mutated AML: results from the AMLSG 09-09 trial. Blood 2020;136:3041-3050.
PMID: 33367545
|
|
|
|